Lanean...
Immune Checkpoint Therapies in Prostate Cancer
Advanced prostate cancer is the second leading cause of death from cancer in the United States. In the era of cancer immunotherapy, it was the first malignancy to demonstrate improved survival with a cancer-specific vaccine; thus, proving that prostate cancer is an immune responsive disease. However...
Gorde:
| Argitaratua izan da: | Cancer J |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847149/ https://ncbi.nlm.nih.gov/pubmed/27111907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000176 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|